Allogeneic Mesenchymal Stromal Cell Therapy (Medical University Of South Carolina)

N/A

Report date: 2024/10/21 13:30:52

Base Information

Drug NameAllogeneic Mesenchymal Stromal Cell Therapy (Medical University Of South Carolina)
Drug Alias NameAllogeneic bone marrow-derived mesenchymal stromal cells (BM-MSCs)Therapy (Medical University Of South Carolina)Autologous bone marrow derived MSCs Therapy (Medical University Of South Carolina)Mesenchymal stem cell therapy(Pandorum International)Mesenchymal stem cell therapy (Pandorum International)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Mesenchymal stem cells therapy
Mechanisms of ActionCell replacements
TargetsNot applicable
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Chronic PainPancreatitis, Chronic +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesMedical University Of South CarolinaPandorum International Inc
China Registration ClassN/A

Develop Information

Active CompaniesMedical University Of South Carolina
Inactive CompaniesPandorum International Inc
Active IndicationsChronic PainPancreatitis, Chronic
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Pneumonia, Viral

Other Information

ATC CodeN/A
Related LinksN/A